HealthDay News — Overall, 17.4% of adults experienced cost burdens, and 9.9% experienced catastrophic cost burdens (CCBs) over a 4-year period, according to a study published in JAMA Internal Medicine ...

Researchers assessed factors influencing contraceptive counseling and use among women with rheumatic disease, including ethnicity, language, and age.

Under a possible rule change outlined in a letter sent to supplement makers, the FDA would still require that warning on the package, but only once, rather than next to every health claim. HealthDay ...

Thomas Münzel, from Johannes Gutenberg University in Germany, and colleagues developed an expert consensus paper to address nicotine itself as a direct cardiovascular toxin, independent of combustion ...

Pediatric patients aged 10 years and older with iron deficiency may now be treated with Accrufer following an expanded FDA approval.

The AAP represents about 67,000 pediatricians nationwide. The cuts come amid ongoing disagreements over vaccines.

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Zoliflodacin is an oral spiropyrimidinetrione antibiotic with activity against multidrug-resistant strains of Neisseria gonorrhoeae.

The Food and Drug Administration (FDA) has approved Exdensur (depemokimab-ulaa), an interleukin-5 antagonist, for add-on maintenance treatment of severe asthma characterized by an eosinophilic ...

The new legislations hope to amend the Higher Education Act of 1965 to restore the full loan limits that were narrowed under Trump’s so-called “Big Beautiful Bill." ...